Skip to main content
Premium Trial:

Request an Annual Quote

Shivom Partners With Cleveland Clinic Spinout Family Care Path

NEW YORK (GenomeWeb) — Shivom announced today that it has signed an agreement to offer Family Care Path's MyLegacy web-based clinical decision support application to its customers.

MyLegacy uses algorithms based on practice guidelines developed by the Cleveland Clinic Genomic Medicine Institute to collect and analyze patient-provided data on personal and extended family history to generate a genetic risk assessment for specific conditions. Family Care Path — a spinout of the Cleveland Clinic — holds an exclusive license to the technology.

Under the terms of the deal, Munich-based Shivom will make MyLegacy available through its online app marketplace. Customers will be able to access the application and schedule a genomic counselling session via Family Care Path's HIPAA-compliant web-based video platform. Shivom noted that it intends to enable the use of its cryptocurrency tokens as a means of payment, as well as an incentive for accessing counselling sessions and related services.

Additional terms were not disclosed.

"Access to your genetic information is really just the beginning; using that information in combination with genetic counselling allows the necessary preventative measures to prevent serious health complications," Shivom CEO Henry Ines said in a statement. "Our collaboration with Family Care Path enables Shivom's customers to access their genetic information using a clinically validated program to help them make lifestyle changes which seek to prevent or suppress hereditary conditions."

In late 2018, Shivom partnered with Lifebit to offer an artificial intelligence-powered platform for identifying the right patients for enrollment in clinical trials. The company, which aims to eventually expand beyond genomics into microbiomics, metabolomics, and other omics technologies, has also forged deals with eMQT, SingularityNet, and Genetic Technologies.